April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Correlation between Fundus Autofluorescence and Spectral Domain Optical Coherence Tomography Measurements in Geographic Atrophy
Author Affiliations & Notes
  • Muneeswar Gupta Nittala
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • Amirhossein Hariri
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • Erin Henry
    Genentech, Inc,, South San Francisco, CA
  • Eric C Strauss
    Genentech, Inc,, South San Francisco, CA
  • Phillip Lai
    Genentech, Inc,, South San Francisco, CA
  • Srinivas R Sadda
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships Muneeswar Gupta Nittala, None; Amirhossein Hariri, None; Erin Henry, Genentech (E); Eric Strauss, Genentech (E); Phillip Lai, Genentech (E); Srinivas Sadda, Allergan (C), Allergan (F), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Genentech (C), Genentech (F), Optoc (C), Optoc (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5896. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Muneeswar Gupta Nittala, Amirhossein Hariri, Erin Henry, Eric C Strauss, Phillip Lai, Srinivas R Sadda; Correlation between Fundus Autofluorescence and Spectral Domain Optical Coherence Tomography Measurements in Geographic Atrophy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5896.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To evaluate the correlation between fundus autofluorescence (FAF) and spectral domain optical coherence tomography (SDOCT) measurements in subjects with geographic atrophy (GA).

 
Methods
 

The MAHALO study (NCT01229215) enrolled 143 eyes of 143 subjects into a Phase Ib/II multicenter, randomized, sham-injection controlled clinical trial of intravitreal lampalizumab for the treatment of GA secondary to age related macular degeneration (AMD). FAF (Heidelberg HRA or Spectralis) and SDOCT (Cirrus) imaging was obtained at multiple time points, including the baseline visit which is the subject of this analysis. The borders of all areas of definite decreased autofluorescence (DDAF) corresponding to GA were manually outlined on FAF images by certified graders at the Doheny Image Reading Center (DIRC) using using validated planimetric grading tools. GA was also delineated automatically from SDOCT images using instrument software (Cirrus v.6.2), Carl Zeiss Meditec inc., Dublin, CA), and segmentation errors were manually corrected prior to computation of GA area. FAF- and SDOCT- derived measurements were correlated.

 
Results
 

The mean baseline GA area measured from FAF images was 8.63 ± 4.22 (range: 2.53 - 17.45) mm2, compared with an automated, uncorrected SDOCT GA area of 7.40 ± 3.53 (range: 0.06 - 15.70) mm2. Despite the presence of apparent OCT segmentation errors, there was significant correlation between FAF and uncorrected SDOCT measurements (r = 0.81; P <0.001). Following manual correction of SDOCT GA segmentation, the measured GA area increased to 7.92 ± 3.60 (SD; range: 2.20 - 15.70), and the correlation with FAF-determined GA area significantly improved (r = 0.97; P < 0.001).

 
Conclusions
 

SDOCT-derived measurements of GA correlate well with areas of DDAF obtained from FAF images. Manual correction of SDOCT segmentation errors can further improve this correlation.

 
Keywords: 412 age-related macular degeneration • 688 retina • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×